These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
568 related items for PubMed ID: 9537870
1. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM. J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870 [Abstract] [Full Text] [Related]
2. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]. Brites D, Rodrigues CM. J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912 [Abstract] [Full Text] [Related]
3. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C. BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939 [Abstract] [Full Text] [Related]
4. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Rodrigues CM, Marín JJ, Brites D. Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117 [Abstract] [Full Text] [Related]
5. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Brites D. Ann Hepatol; 2002 Sep; 1(1):20-8. PubMed ID: 15114292 [Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E. Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728 [Abstract] [Full Text] [Related]
7. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, Marin JJ. J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319 [Abstract] [Full Text] [Related]
8. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Kondrackiene J, Beuers U, Kupcinskas L. Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129 [Abstract] [Full Text] [Related]
9. New Insights on Intrahepatic Cholestasis of Pregnancy. Floreani A, Gervasi MT. Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298 [Abstract] [Full Text] [Related]
10. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. Geenes V, Lövgren-Sandblom A, Benthin L, Lawrance D, Chambers J, Gurung V, Thornton J, Chappell L, Khan E, Dixon P, Marschall HU, Williamson C. PLoS One; 2014 Feb; 9(1):e83828. PubMed ID: 24421907 [Abstract] [Full Text] [Related]
11. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942 [Abstract] [Full Text] [Related]
13. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group. Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395 [Abstract] [Full Text] [Related]
14. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Lee RH, Mara Greenberg, Metz TD, Pettker CM. Am J Obstet Gynecol; 2021 Feb 07; 224(2):B2-B9. PubMed ID: 33197417 [Abstract] [Full Text] [Related]
15. Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. Pata O, Vardarelı E, Ozcan A, Serteser M, Unsal I, Saruç M, Unlü C, Tözün N. Turk J Gastroenterol; 2011 Dec 07; 22(6):602-5. PubMed ID: 22287405 [Abstract] [Full Text] [Related]
16. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy. Tribe RM, Dann AT, Kenyon AP, Seed P, Shennan AH, Mallet A. Am J Gastroenterol; 2010 Mar 07; 105(3):585-95. PubMed ID: 19904249 [Abstract] [Full Text] [Related]
17. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J. Hepatology; 1997 Dec 07; 26(6):1573-9. PubMed ID: 9398000 [Abstract] [Full Text] [Related]
18. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C. J Hepatol; 2021 May 07; 74(5):1087-1096. PubMed ID: 33276032 [Abstract] [Full Text] [Related]
19. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini A. BJOG; 2004 Jan 07; 111(1):17-21. PubMed ID: 14687046 [Abstract] [Full Text] [Related]